Your session is about to expire
← Back to Search
All Patients: for Coronavirus (CAPTURE-2 Trial)
CAPTURE-2 Trial Summary
This trial evaluates how well the LumiraDx SARS-CoV-2 Ab Test works compared to the reference method.
- Coronavirus
CAPTURE-2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CAPTURE-2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently using or have used an experimental treatment or device in the last 30 days.
- Group 1: All Patients:
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experimental program open to new participants?
"Yes, as per the information posted on clinicaltrials.gov this medical trial is actively seeking participants. The initial posting was made on August 20th 2020 and most recently updated on October 20th 2020. In total 200 patients need to be recruited from 4 distinct sites for this study."
To what extent is this investigation being administered across various sites?
"The research program is currently seeking participants at Physicians Quality Care of Jackson in Tennessee, Centura Health Physician Group's Northglenn Office in Colorado, Professional Research Network of Kansas in Wichita, and 4 additional sites."
What is the current enrollment size of this research project?
"LumiraDx UK Limited is the study sponsor and they need 200 eligible patients to complete their trial. This will take place at Physicians Quality Care of Jackson in Tennessee and Centura Health Physician Group, Northglenn Office in Colorado."
Share this study with friends
Copy Link
Messenger